Home/Pipeline/ALS Pathway Discovery

ALS Pathway Discovery

Amyotrophic Lateral Sclerosis

PreclinicalActive

Key Facts

Indication

Amyotrophic Lateral Sclerosis

Phase

Preclinical

Status

Active

Company

AI‑powered visual biology platform that enables autonomous hypothesis testing inside cells for drug discovery.

Drug	Company	Phase	Status
Cell Therapy for ALS	INCELL	Unknown	Active
ALS Research	GliaPharm	Research	Active
ALS Disease Model Service	NeuroProof	Pre-clinical	Active
ALS Biomarker Program	Linus Biotechnology	Pre-clinical	Active
ALS Research (post-RADICAVA)	Tanabe Pharma America	Preclinical/Research	Active
ALS Program	Biorchestra	Preclinical	Active
Program(s) for ALS	AviadoBio	Pre-clinical	Active
TCD601 for ALS	ITB Med	Phase 2	Active
ILB® for ALS	TikoMed	Phase 2	Active
ALS Patient-Led Research Initiative	BGI	Research	Active
Pridopidine	Prilenia Therapeutics	Phase 3	Active
Foralumab (intranasal)	Tiziana Life Sciences	Phase 2	Planned (2H 2025)